ClariPulmo
ClariPulmo is an AI-powered tri-functional solution kit best suited for low-dose lung CT screening. Our powerful pre-trained deep learning model provides accurate quantitative analysis of low-attenuation and high-attenuation lesions such as emphysema and pneumonia from low-dose CT images, despite strong image noise and varying scan conditions. The ClariPulmo in conjunction with the ClariCT.AI can help achieve the best practice in lung screening by reducing noise induced bias with this 3D reporting.
How can ClariPulmo help with Covid-19?
• Infection with COVID-19 has symptoms such as high fever, cough and pneumonia
• Early detection of pneumonia is vital because it may initially show mild symptoms similar to cold, but may rapidly worsen to be deadly
• ClariPulmo can help with early diagnosis by detecting and analyzing areas suspected of COVID-19 pneumonia on CT








ClariPulmo Benefits
Fully Automated Emphysema Reporting
- Automatic segmentation and visualization for lungs and airways
- Automatic LAA and HAA analysis
- Automatic measurement of volume and diameter
ClariPulmo Provides
- Viewer displays volume-rendered images
- Report includes results with location as well as 3D rendered image
- Report presents findings with their volume and diameter
- Denoising and kernel normalization options enable accurate lung density quantification in low-dose CT scans
One-Stop Solution
- Ultra-low-dose CT solution ClariCT.AI – Fully automated emphysema reporting ClariPulmo
- Double solution package at one unit price
- Fully integrated fully automatic workflow
- Cloud service option available
Operating Costs Reduction
- No need to change the existing CT scanners
How It Works
Fully compliant with DICOM standards, ClariPulmo allows easy and seamless integration with any CT scanners and PACS systems.
We are looking for Hospitals/Clinics, Radiologists, PACS Companies, Manufacturers, Dealers for New or Used Medical Equipment
